Spinal microglia and astrocytes: two key players in chronic visceral pain pathogenesis
Chronic visceral pain (CVP) is one of the common symptoms of many diseases triggered by
underlying diseases of the internal organs of the human body. Its causes include vascular …
underlying diseases of the internal organs of the human body. Its causes include vascular …
The opioid epidemic from the acute care hospital front line
PE Macintyre - Anaesthesia and Intensive Care, 2022 - journals.sagepub.com
Prescription opioid use has risen steeply for over two decades, driven primarily by advocacy
for better management of chronic non-cancer pain, but also by poor opioid stewardship in …
for better management of chronic non-cancer pain, but also by poor opioid stewardship in …
Pharmaceutical opioid poisonings in Victoria, Australia: rates and characteristics of a decade of emergency department presentations among nine pharmaceutical …
Background and aims Pharmaceutical opioids are a significant contributor to the global
'opioid crisis', yet few studies have comprehensively distinguished between opioid types. We …
'opioid crisis', yet few studies have comprehensively distinguished between opioid types. We …
Antinociceptive activities and mechanism of action of Cepharanthine
XY Wei, JD Long, JR Chai, J Chen, JP Gao… - Biochemical and …, 2022 - Elsevier
Cepharanthine is an alkaloid that isolated from Stephania cepharantha Hayata, however, its
analgesic properties are unclear and the molecular targets that mediating Cepharanthine …
analgesic properties are unclear and the molecular targets that mediating Cepharanthine …
Comparing opioid types in the persistence of opioid use following surgical admission: a study protocol for a retrospective observational linkage study comparing …
Introduction Each year, an estimated two million Australians commence opioids, with 50 000
developing longer-term (persistent) opioid use. An estimated 3%–10% of opioid-naïve …
developing longer-term (persistent) opioid use. An estimated 3%–10% of opioid-naïve …
[HTML][HTML] Characterizing the Experience of Tapentadol Nonmedical Use: Mixed Methods Study
SK Vosburg, T Dailey-Govoni, J Beaumont… - JMIR Formative …, 2022 - formative.jmir.org
Background The prevalence of abuse, diversion, and web-based endorsement of tapentadol
(extended-release [ER], immediate-release [IR]) has been characterized as low compared …
(extended-release [ER], immediate-release [IR]) has been characterized as low compared …
[HTML][HTML] Protocol: Comparing opioid types in the persistence of opioid use following surgical admission: a study protocol for a retrospective observational linkage study …
T Lam, N Biggs, T Xia, J Evans, J Stevens, M da Gama… - BMJ Open, 2022 - ncbi.nlm.nih.gov
Introduction Each year, an estimated two million Australians commence opioids, with 50 000
developing longer-term (persistent) opioid use. An estimated 3%–10% of opioid-naïve …
developing longer-term (persistent) opioid use. An estimated 3%–10% of opioid-naïve …
Predictors of older adults' chronic pain in the context of opioid adverse drug events
DD McDonald, SJ Walsh - Journal of the American Association of …, 2022 - journals.lww.com
Background: Factors predictive of chronic pain in older adults could help focus prevention
and treatment efforts for those most at risk of chronic pain. Purpose: The objective of the …
and treatment efforts for those most at risk of chronic pain. Purpose: The objective of the …